Roberto Parise‐Filho

1.1k total citations
42 papers, 782 citations indexed

About

Roberto Parise‐Filho is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Roberto Parise‐Filho has authored 42 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Organic Chemistry and 10 papers in Computational Theory and Mathematics. Recurrent topics in Roberto Parise‐Filho's work include Computational Drug Discovery Methods (10 papers), Bioactive Compounds and Antitumor Agents (9 papers) and Histone Deacetylase Inhibitors Research (5 papers). Roberto Parise‐Filho is often cited by papers focused on Computational Drug Discovery Methods (10 papers), Bioactive Compounds and Antitumor Agents (9 papers) and Histone Deacetylase Inhibitors Research (5 papers). Roberto Parise‐Filho collaborates with scholars based in Brazil, United Kingdom and United States. Roberto Parise‐Filho's co-authors include Maurício T. Tavares, Elizabeth Igne Ferreira, Jeanine Giarolla, Soraya da Silva Santos, Omar A. El Seoud, Kerly Fernanda Mesquita Pasqualoto, Ricardo Azevedo, Adilson Kleber Ferreira, Carlos A. Brandt and André Rolim Baby and has published in prestigious journals such as Molecules, International Journal of Pharmaceutics and European Journal of Medicinal Chemistry.

In The Last Decade

Roberto Parise‐Filho

39 papers receiving 763 citations

Peers

Roberto Parise‐Filho
Najla Altwaijry Saudi Arabia
Roberto Parise‐Filho
Citations per year, relative to Roberto Parise‐Filho Roberto Parise‐Filho (= 1×) peers Najla Altwaijry

Countries citing papers authored by Roberto Parise‐Filho

Since Specialization
Citations

This map shows the geographic impact of Roberto Parise‐Filho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Parise‐Filho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Parise‐Filho more than expected).

Fields of papers citing papers by Roberto Parise‐Filho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Parise‐Filho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Parise‐Filho. The network helps show where Roberto Parise‐Filho may publish in the future.

Co-authorship network of co-authors of Roberto Parise‐Filho

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Parise‐Filho. A scholar is included among the top collaborators of Roberto Parise‐Filho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Parise‐Filho. Roberto Parise‐Filho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braga, Rodolpho C., Cleber C. Melo‐Filho, Maurício T. Tavares, et al.. (2025). Dona Flor and her two husbands: Discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatment. Computers in Biology and Medicine. 197(Pt A). 110990–110990.
2.
Tavares, Maurício T., et al.. (2025). Enhancing venetoclax efficacy in leukemia through association with HDAC inhibitors. Cell Death Discovery. 11(1). 147–147. 2 indexed citations
3.
Parise‐Filho, Roberto, et al.. (2024). Natural and Synthetic Capsaicin Analogues: A Comprehensive Review of Biological Effects and Synthetic Pathways. Current Medicinal Chemistry. 32(24). 4963–4991.
4.
Primi, Marina Candido, Claudia Ruiz, Thales Kronenberger, et al.. (2023). HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents. European Journal of Medicinal Chemistry. 263. 115935–115935. 4 indexed citations
5.
Parise‐Filho, Roberto, et al.. (2022). New Kinase and HDAC Hybrid Inhibitors: Recent Advances and Perspectives. Future Medicinal Chemistry. 14(10). 745–766. 6 indexed citations
6.
Tavares, Maurício T., et al.. (2021). Peppers: A “Hot” Natural Source for Antitumor Compounds. Molecules. 26(6). 1521–1521. 11 indexed citations
7.
Tavares, Maurício T., Thales Kronenberger, Gláucio Monteiro Ferreira, et al.. (2021). Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry. 35. 116085–116085. 8 indexed citations
8.
Bhardwaj, Rajesh, et al.. (2020). Natural product inspired optimization of a selective TRPV6 calcium channel inhibitor. RSC Medicinal Chemistry. 11(9). 1032–1040. 26 indexed citations
9.
Kronenberger, Thales, Gláucio Monteiro Ferreira, Soraya da Silva Santos, et al.. (2020). Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors. Bioorganic & Medicinal Chemistry. 28(15). 115600–115600. 11 indexed citations
10.
Tavares, Maurício T., et al.. (2019). Crystal Structure of GenD2, an NAD-Dependent Oxidoreductase Involved in the Biosynthesis of Gentamicin. ACS Chemical Biology. 14(5). 925–933. 12 indexed citations
11.
Rosado, Catarina, Camila Areias de Oliveira, Fernanda Daud Sarruf, et al.. (2019). Another Reason for Using Caffeine in Dermocosmetics: Sunscreen Adjuvant. Frontiers in Physiology. 10. 519–519. 38 indexed citations
12.
Tavares, Maurício T., Ricardo Azevedo, Rajesh Bhardwaj, et al.. (2019). Capsaicin-like analogue induced selective apoptosis in A2058 melanoma cells: Design, synthesis and molecular modeling. Bioorganic & Medicinal Chemistry. 27(13). 2893–2904. 17 indexed citations
13.
Santos, Soraya da Silva, et al.. (2019). Dendrimers in the context of nanomedicine. International Journal of Pharmaceutics. 573. 118814–118814. 165 indexed citations
14.
Gattass, Cerli Rocha, Deivid Costa Soares, Christian Ferreira, et al.. (2016). Oleanolic acid (OA) as an antileishmanial agent: Biological evaluation and in silico mechanistic insights. Parasitology International. 65(3). 227–237. 31 indexed citations
15.
Ferreira, Adilson Kleber, Maurício T. Tavares, Kerly Fernanda Mesquita Pasqualoto, et al.. (2015). RPF151, a novel capsaicin-like analogue: in vitro studies and in vivo preclinical antitumor evaluation in a breast cancer model. Tumor Biology. 36(9). 7251–7267. 21 indexed citations
16.
Pasqualoto, Kerly Fernanda Mesquita, Adilson Kleber Ferreira, Maurício T. Tavares, et al.. (2013). RPF101, a new capsaicin-like analogue, disrupts the microtubule network accompanied by arrest in the G2/M phase, inducing apoptosis and mitotic catastrophe in the MCF-7 breast cancer cells. Toxicology and Applied Pharmacology. 266(3). 385–398. 35 indexed citations
17.
Ferreira, Adilson Kleber, Kerly Fernanda Mesquita Pasqualoto, Ricardo Azevedo, et al.. (2013). Cytotoxic effects of dillapiole on MDA-MB-231 cells involve the induction of apoptosis through the mitochondrial pathway by inducing an oxidative stress while altering the cytoskeleton network. Biochimie. 99. 195–207. 31 indexed citations
18.
Tavares, Maurício T., et al.. (2013). N-[(1,3-Benzodioxol-5-yl)methyl]benzenesulfonamide: an analogue of capsaicin. Acta Crystallographica Section E Structure Reports Online. 69(11). o1700–o1700. 1 indexed citations
19.
Parise‐Filho, Roberto, Kerly Fernanda Mesquita Pasqualoto, Adilson Kleber Ferreira, et al.. (2012). Dillapiole as Antileishmanial Agent: Discovery, Cytotoxic Activity and Preliminary SAR Studies of Dillapiole Analogues. Archiv der Pharmazie. 345(12). 934–944. 35 indexed citations
20.
Parise‐Filho, Roberto, et al.. (2006). Design, synthesis, and in vivo evaluation of oxamniquine methacrylate and acrylamide prodrugs. Bioorganic & Medicinal Chemistry. 15(3). 1229–1236. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026